Literature DB >> 17727260

Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs.

Oliver Thews1, Birgit Gassner, Debra K Kelleher, Gerald Schwerdt, Michael Gekle.   

Abstract

In the microenvironment of solid growing tumors, pronounced hypoxia or extracellular acidosis is commonly found. The aim of this study was the analysis of the cytotoxic effect of different chemotherapeutic agents (cisplatin, daunorubicin, docetaxel) under these conditions in vitro. Prostate carcinoma cells (R3327-AT1) were exposed to hypoxia (pO2 < 0.5 mmHg) or extracellular acidosis (pH = 6.6) for 6h. After 3h, cytotoxic drugs were added. The cytotoxic effect was assessed by measuring caspase 3-activity (apoptosis), LDH release (necrosis) and repopulation of the cells after chemotherapy (cell death). Compared to aerobic control conditions, severe hypoxia over 6 h per se led to a slight increase in apoptosis, necrosis and cell death. With all three chemotherapeutic agents, hypoxia led to a reduced (by approx. 25%) caspase 3-activity and a marked increase in necrosis. However, the overall cytotoxicity of the drug was not affected by O2-deficiency. By contrast, during extracellular acidosis, the cytotoxic effect of daunorubicin was reduced by 40%, preferentially due to a marked reduction in apoptosis. With cisplatin and docetaxel no change in overall cell death was detected. However, for daunorubicin the tumor-pH seems to have a strong impact on cytotoxicity. With this chemotherapeutic drug the therapeutic efficacy is markedly reduced in an acidotic environment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727260     DOI: 10.1007/978-0-387-71764-7_21

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor Gpr65 signaling to Mek/Erk.

Authors:  Christopher Ryder; Karen McColl; Fei Zhong; Clark W Distelhorst
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

2.  Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs.

Authors:  Elodie Jouberton; Aurélien Voissiere; Frédérique Penault-Llorca; Florent Cachin; Elisabeth Miot-Noirault
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation.

Authors:  K Masur; C Vetter; A Hinz; N Tomas; H Henrich; B Niggemann; K S Zänker
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

Review 4.  Hyperglycemia, a neglected factor during cancer progression.

Authors:  Wanxing Duan; Xin Shen; Jianjun Lei; Qinhong Xu; Yongtian Yu; Rong Li; Erxi Wu; Qingyong Ma
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

5.  Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery.

Authors:  Guanren Zhao; Ling Long; Lina Zhang; Mingli Peng; Ting Cui; Xiaoxun Wen; Xing Zhou; Lijun Sun; Ling Che
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

6.  Extracellular acidity enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis via DR5 in gastric cancer cells.

Authors:  Ran Hong; Song Iy Han
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

7.  Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance.

Authors:  Hoda Soleymani Abyaneh; Amir Hassan Soleimani; Mohammad Reza Vakili; Rania Soudy; Kamaljit Kaur; Francesco Cuda; Ali Tavassoli; Afsaneh Lavasanifar
Journal:  Pharmaceutics       Date:  2018-10-21       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.